[Clinical reevaluation of continuous intravenous infusion of 5-fluorouracil--plasma concentrations and clinical dose by continuous intravenous and 60-min infusions].

MLA

Nakatsu, T., et al. “[Clinical Reevaluation of Continuous Intravenous Infusion of 5-Fluorouracil--Plasma Concentrations and Clinical Dose by Continuous Intravenous and 60-Min Infusions].” Gan to Kagaku Ryoho. Cancer & Chemotherapy, vol. 17, no. 2, Feb. 1990, pp. 253–58. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=2301952&authtype=sso&custid=ns315887.

APA

Nakatsu, T., Yokoyama, I., Tsuyuki, K., Soh, Y., Hanai, G., Matsumoto, H., Kubo, H., Matsumoto, K., Nohga, K., & Koyanagi, H. (1990). [Clinical reevaluation of continuous intravenous infusion of 5-fluorouracil--plasma concentrations and clinical dose by continuous intravenous and 60-min infusions]. Gan to Kagaku Ryoho. Cancer & Chemotherapy, 17(2), 253–258.

Chicago

Nakatsu, T, I Yokoyama, K Tsuyuki, Y Soh, G Hanai, H Matsumoto, H Kubo, K Matsumoto, K Nohga, and H Koyanagi. 1990. “[Clinical Reevaluation of Continuous Intravenous Infusion of 5-Fluorouracil--Plasma Concentrations and Clinical Dose by Continuous Intravenous and 60-Min Infusions].” Gan to Kagaku Ryoho. Cancer & Chemotherapy 17 (2): 253–58. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=2301952&authtype=sso&custid=ns315887.